InMed Pharmaceuticals Inc.·4

Mar 5, 3:20 PM ET

HSU ERIC C 4

4 · InMed Pharmaceuticals Inc. · Filed Mar 5, 2024

Insider Transaction Report

Form 4
Period: 2024-03-04
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2024-03-0430952,545 total
    Exercise: $364.72From: 2019-03-04Exp: 2024-03-04Common shares (309 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$495 using an exchange rate of C$1.3572 = $US1.00

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT